Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiologix
Irvine, California, USAcardiologix.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
CardioLogix was a medical technology company specializing in the development of percutaneous heart valve repair technologies. The company's primary focus was on creating minimally invasive solutions for mitral regurgitation, a condition where the heart's mitral valve does not close tightly. Its lead technology was a catheter-based system designed to repair the mitral valve without requiring invasive open-heart surgery. In May 2007, CardioLogix was acquired by Edwards Lifesciences for approximately 27 million in cash plus potential milestone payments. This acquisition bolstered Edwards Lifesciences' leadership in the structural heart disease market and expanded its transcatheter therapy pipeline.
- Therapeutic areas
- Cardiovascular
- Modalities
- Device
- Industry
- Therapeutic Medical Devices
Beyond the preview
Go deeper on Cardiologix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cardiologix.